We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tencent Music
TME
$13.2B
| $83.1M | 0.2% |
5,914,271
-2,898,073
| -33% | -$38.9M |
|
127
Blackrock
BLK
$165B
| $81.5M | 0.19% |
103,552
-19,388
| -16% | -$15.1M |
|
128
Fortune Brands Innovations
FBIN
$4.86B
| $81.1M | 0.19% |
1,248,174
-547,677
| -30% | -$39.5M |
|
129
UGI
UGI
$8.09B
| $81M | 0.19% |
3,537,729
+788,457
| +29% | +$19.1M |
|
130
O'Reilly Automotive
ORLY
$70.6B
| $80.8M | 0.19% |
1,147,725
-179,265
| -14% | -$12.4M |
|
131
Wintrust Financial
WTFC
$10.3B
| $80.4M | 0.19% |
815,466
+14,087
| +2% | +$1.38M |
|
132
Sarepta Therapeutics
SRPT
$2.21B
| $80.3M | 0.19% |
508,329
-101,887
| -17% | -$13.1M |
|
|
DVAX
133
DELISTED
Dynavax Technologies
DVAX
| $80.3M | 0.19% |
7,146,769
-842,005
| -11% | -$9.8M |
|
134
RPM International
RPM
$12.9B
| $80.1M | 0.19% |
744,309
+8,730
| +1% | +$967K |
|
135
Micron Technology
MU
$1.04T
| $80.1M | 0.19% |
608,851
-705,063
| -54% | -$88.8M |
|
136
Trip.com Group
TCOM
$24.6B
| $79.8M | 0.19% |
1,698,434
-143,779
| -8% | -$7.32M |
|
137
Advanced Micro Devices
AMD
$805B
| $79.4M | 0.19% |
489,230
-360,003
| -42% | -$57.9M |
|
138
Xylem
XYL
$25.1B
| $79.2M | 0.19% |
584,012
-200,603
| -26% | -$27.3M |
|
139
Abbott
ABT
$178B
| $79.1M | 0.19% |
760,781
-110,149
| -13% | -$11.7M |
|
140
PTC
PTC
$14.8B
| $78.8M | 0.19% |
433,892
+10,462
| +2% | +$1.87M |
|
141
Uber
UBER
$148B
| $77.9M | 0.18% |
1,071,393
-71,227
| -6% | -$4.95M |
|
142
Amphastar Pharmaceuticals
AMPH
$1.02B
| $77.8M | 0.18% |
1,944,800
-132,301
| -6% | -$5.48M |
|
143
Vertiv
VRT
$91.4B
| $77.7M | 0.18% |
897,909
+215,138
| +32% | +$19.6M |
|
144
FedEx
FDX
$74B
| $76.5M | 0.18% |
254,981
-8,127
| -3% | -$2.13M |
|
145
Zscaler
ZS
$31.3B
| $75.9M | 0.18% |
394,698
+61,037
| +18% | +$10.9M |
|
146
ExxonMobil
XOM
$679B
| $75.2M | 0.18% |
652,992
-66,042
| -9% | -$7.69M |
|
147
Insulet
PODD
$9.56B
| $74.5M | 0.18% |
369,113
+103,266
| +39% | +$18.6M |
|
|
GTLS
148
DELISTED
Chart Industries
GTLS
| $74M | 0.18% |
512,603
-1,896
| -0.4% | -$286K |
|
149
Public Storage
PSA
$55.2B
| $73.3M | 0.17% |
254,819
+32,662
| +15% | +$9.01M |
|
150
Wabtec
WAB
$47B
| $73.3M | 0.17% |
463,683
+1,680
| +0.4% | +$268K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.